Cinepazide maleate
A cerebral vasodilator that acts as a calcium blocker; protect neuronal cells against OGD injury by suppressing OGD-induced oxidative stress and preserving mitochondrial functions.Ischemia Approved (In Vitro) :Cinepazide Maleate (intravenous injection; 30 mg/kg) potentiates the vertebral vasodilator response of dogs to intravertebral adenosine and cyclic AMP, while cinnarizine reduces their vasodilator effects.Cinepazide Maleate (intravertebral injection; 1-10 mg/kg) increases vertebral blood flow in a dose-related manner in dogs.
Product Specifications
CAS Number
26328-04-1
Field of Research
Pharmacology & Drug Discovery
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
COC1=CC (=CC (=C1OC) OC) /C=C/C (=O) N2CCN (CC2) CC (=O) N3CCCC3.C (=C\C (=O) O) \C (=O) O
Molecular Formula
C26H35N3O9
Molecular Weight
533.5708
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Piperazine, 1-[2-oxo-2- (1-pyrrolidinyl) ethyl]-4-[1-oxo-3- (3,4,5-trimethoxyphenyl) -2-propenyl]-, (E) -, (2Z) -2-butenedioate (1:1)
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
